Phytoestrogens Are Partial Estrogen Agonists
in the Adult Male Mouse
Sari Makela,' Risto Santti,' Leena Salo,1 and John A. McLachlan2
1lnstitute of Biomedicine and Medicity Research Laboratory, University of Turku, Turku, Finland; 2Tulane/Xavier
Center for Bioenvironmental Research, Tulane University, New Orleans, Louisiana
The intake, as well as serum and urinary concentrations, of phytoestrogens is high in countries where incidence of prostate cancer is low,
suggesting a chemopreventive role for phytoestrogens. Their significance could be explained by the ability to antagonize the action of more potent
endogenous estrogens in initiation or promotion of tumor formation. We have studied estrogenicity and antiestrogenicity of dietary soy and two
phytoestrogens, coumestrol and daidzein, in our neoDES mouse model for the study of prostatic neoplasia. Soy was chosen because it is rich in
phytoestrogens, is widely used in Oriental diets, and has antiestrogenic and anticarcinogenic properties in the neoDES mouse when given from
fertilization onward. In short-term tests with adult animals, no evidence for estrogenicity or antiestrogenicity (capability to antagonize the action of
1 7,B-estradiol) of soy was found when development of epithelial metaplasia and expression of c-fos protooncogene in prostate were used as end
points of estrogen action. Estrogenic activity of coumestrol and daidzein on c-fos expression was subtle. Coumestrol, either given alone or in combination with 17,B-estradiol, had no effect on development of epithelial metaplasia. These marginal or missing effects in adult males could be interpreted by assuming that the neonatal period is more critical for estrogenic or antiestrogenic action of soy and phytoestrogens. Once initiated,
estrogen-related lesions would develop spontaneously. Alternatively, the chemopreventive action of soy is not due to antiestrogenicity of soyderived phytoestrogens. - Environ Health Perspect 103(Suppl 7):123-127 (1995)
Key words: accessory sex glands, c-fos, coumestrol, daidzein, estrogens, male, mouse, phytoestrogens, prostate, soy
Introduction
Dietary soy has chemopreventive properties in several animal models for cancers
(1-3). There is also suggestive evidence
that dietary soy (tofu) is chemopreventive
in human prostate cancer (4). Using the
developmentally estrogenized mouse model
(5,6), we have shown that the estrogenrelated inhibition of prostatic growth is
reduced and the development of dysplastic
changes is delayed in the prostate when the
animals are kept on soy-containing feed
from fertilization onward (7). Both the
number of animals showing dysplasia and
This paper was presented at the Symposium on
Estrogens in the Environment, III: Global Health
Implications held 9-11 January 1994 in Washington,
DC. Manuscript received: March 15, 1995; manuscript accepted: April 4, 1995.
Hanna Laine, Leena Simola, Silja Simola, and Tuula
Tanner are acknowledged for their skilful technical
assistance. This work was financially supported by
Yrjo Jahnsson Foundation, Turku University
Foundation,and Emil Aaltonen Foundation.
Address correspondence to Dr. Sari Makela,
University of Turku, Institute of Biomedicine,
Department of Anatomy, Kiinamyllynkatu 10,
FIN-20520 Turku, Finland. Telephone: 358-21-633
7361. Fax: 358-21-633 7352.
Abbreviations used: DMSO, dimethyl sulfoxide;
PBS, phosphate-buffered saline; bw, body weight;
CG, coagulating gland; DES, diethylstilbestrol; DLP,
dorsolateral prostate (lobe); DP, dorsal prostate (lobe);
LP, lateral prostate (lobe); neoDES mouse, neonatally
DES-treated mouse; PC, prostatic cancer; PIN, prostatic intraepithelial neoplasia; SV, seminal vesicle; T,
testis; ER, estrogen receptor; E2, 71 W estradiol.
Environmental Health Perspectives
also the severity of the alterations in dysplastic epithelium were lower in animals given
soy. Morphologically the dysplastic lesions
in the prostate of neoDES animals are similar to prostatic intraepithelial neoplasia
(PIN) in human prostate (8). Although no
progression to carcinomas with invasion of
surrounding tissues or metastasis could be
demonstrated, the morphological changes
and increased expression of protooncogenes in developmentally estrogenized mice
suggest an increased potential for benign
and malignant growth (Table 1).
Soy is rich in phytoestrogens, weakly
estrogenic nonsteroidal compounds. Their
urinary excretion (particularly that of
isoflavones) correlates with the ingestion
of soy in our animal experiments (7). In
humans, urinary excretion and serum
concentrations of phytoestrogens are
higher in countries where the incidence of
prostate cancer is low (9,10). This suggests that phytoestrogens may account for
the chemopreventive action of soy in
prostate carcinogenesis.
The mechanisms of the possible
chemopreventive action of phytoestrogens
are not known. Their significance could be
explained by their ability to antagonize
the action of more potent endogenous
estrogens in initiation or promotion of
carcinogenesis, although currently no
direct evidence for this action is available.
The mouse model based on neonatal
diethylstilbestrol treatment (neoDES
model) is particularly suitable for testing
this hypothesis. In neoDES mice the histological response to 17p-estradiol in terms
of metaplastic transformation and the
17p-estradiol-induced expression of c-fos
protooncogene are greatly enhanced. Based
on these end points of estrogen action, we
have tested the estrogenicity and antiestrogenicity of dietary soy and two structurally
different phytoestrogens, coumestrol and
daidzein, both known to be present in soy.
Materials and Methods
Animals and Diets
Outbred Han-NMRI mice (produced by
the Animal Quarters, Institute of
Biomedicine, University of Turku, Turku,
Finland) were used throughout the study.
The test protocols were approved by the
Turku University Committee on the
Laboratory Animal Center. The animals
were given free access to feed and tap
water. A soyfree diet, where soy is substituted with casein, was purchased from
Finnewos (Helsinki, Finland) and Special
Diet Services, (Witham, Essex, United
Kingdom). A standard soy-containing laboratory feed for mice (Ewos R3) containing cereals, wheat germ, wheat middlings,
roasted soy meal (7%), fish protein concentrate, fodder yeast, minerals, animal
and vegetable fat, vitamin concentrate,
123
MAKELA ETAL.
Table 1. Effects of neonatal estrogenization in mouse urethroprostatic complex (2 pg of diethylstilbestrol per day
on days 1 to 3 after birth).
Prostatic growth
Permanent growth inhibition of all lobes (5)
Tissue composition
Increase in the relative volume of prostatic interacinar stroma (5)
Increased amount of periurethral glands (5)
Epithelial structure
Hyperplasia and dysplasia in posterior periurethral region and collecting ducts
(sites adjacent to estrogen receptor-positive stroma) (6)
Expression of estrogenPermanent increase in c-myc and c-fos expression [(6); S Makel3, unpublished
responsive protooncogenes
results]
Response to secondary
Enhanced estrogen sensitivity (estimated by the development of epithelial
estrogen treatment
metaplasia in collecting ducts and expression of c-fos oncogene after
treatment with 17p-estradiol) [(6); S Makela, unpublished results]
Voiding function
Altered voiding pattern (increased voiding frequency, decreased voiding volumes)
(S Makela, unpublished results)
Decreased ratio of urinary flow to bladder pressure (S Makela, unpublished results)
Immune system
Inflammatory changes (5)
intensities of autoradiographic films were
scanned with the Microcomputer Imaging
Device (MCID) by using M4, version 2.1
software program (Imaging Research Inc.,
Ontario, Canada). The intensity values of
c-fos were corrected by the corresponding
intensity values obtained after hybridization with mouse 28S ribosomal RNA
probe. The 4.8 kb SalI-EcoRI fragment of
mouse 28S ribosomal RNA cDNA was
32P-dCTP labeled by random priming.
Resufts
Effects of Dietary Soy and Coumestrol
on Development of Squamous
Epithelial Metaplasia
and trace element concentrate was prepared by Finnewos, Helsinki, Finland.
The animals were kept on soyfree diet, and
the soy-containing diet was used only in
the experiments.
Neonatal Estrogenization with
sections were carefully studied for the presence of squamous epithelial metaplasia in
the periurethral collecting ducts and proximal parts of coagulating gland, dorsolateral
prostate, and seminal vesicles.
diethylstilbestrol (DES) in 20 pl of corn oil
per day for the first 3 days after birth.
and, after 7 days, they were injected sc with
17,B-estradiol (100 pg/animal), coumestrol
(200 pg/animal), or daidzein (200 pg/animal) diluted in corn oil (100 pl/animal).
The controls received the vehicle only. In
the soy experiment, the animals were kept
on the soy diet from castration onward.
Animals were sacrificed 3, 6, or 12 hr after
injection and urethroprostatic blocks were
removed. Tissues were transferred to a
petri dish containing phosphate-buffered
saline (PBS) and prostatic lobes, seminal
vesicles, and prostatic urethra were dissected under a microscope. Tissue samples
were immediately frozen in liquid nitrogen
and stored at -70°C. Total RNAs were
extracted with the single step method (11).
Fifteen-microgram aliquots of total RNA Induction of c-Jbs Expression
were size-fractionated in 1% agarose/for- 17J-Estradiol induced the expression of cmaldehyde gels and blotted onto nylon fos in neoDES mice given a soy-free diet.
membrane (GeneScreen, DuPont, NEN, After the sc injection of 170-estradiol
Boston, MA). The filters were hybridized (100 pg/animal) the increased expression
and washed as suggested by the manufac- was evident in the prostatic urethra and
turer. The 32P-labeled c-fos antisense RNA coagulating glands at 3 to 12 hr after
probe was synthesized from the insert in a injection (Figure 2).
pGEM vector (Promega, Madison, WI)
Soy given to neoDES animals for 1
according to the manufacturers directions, week before 17,B-estradiol injection had no
using Sp6 RNA polymerase; the radiola- effect on the expression. Further, coumebeled probe was added directly to the pre- strol and daidzein in a dose of 200 pg/anihybridization mixture. The c-fos probe was mal sc showed weak estrogenic action
kindly provided by George Stancel (Figure 2), but there is no evidence that
(University of Texas, Houston TX). This soy acts as an antiestrogen based on the
mouse c-fos probe was originally obtained induction of c-fos expression.
by digestion and subcloning of mouse pcfos-3 (12). For quantitation, the signal
Induction ofc-bs Expression
Diethyistilbestrol (neoDES Treatnent) Adult (3-5 months of age) neoDES mice
Male pups were injected sc with 2 pg of were castrated under barbiturate anesthesia
Induction ofMetaplastic Reaction
Adult neoDES mice (3-5 months of age)
were castrated under barbiturate anesthesia.
In soy experiments the animals were
divided into four groups: group 1 continued on the soyfree diet; group 2 was transferred to the soy-containing diet; group 3
received an sc implant with 50 pg estradiol
and continued on the soyfree diet; and
group 4 received an sc implant with 50 pg
estradiol and was transferred to the soycontaining diet. In experiments with
coumestrol, the animals were divided into
four groups: group 1 received the vehicle,
20 pl of dimethyl sulfoxide (DMSO) per
day sc; group 2 received 25 pg of estradiol
in DMSO sc per day; group 3 received 50
pg of coumestrol in DMSO sc per day; and
group 4 received both estradiol and
coumestrol. After 10 days (soy experiment)
and 7 days (coumestrol experiment) the
animals were sacrificed; the urethroprostatic blocks were removed and used for histologic preparations. Tissue blocks were fixed
whole in Bouin's fixative, dehydrated, and
embedded in paraffin. Serial horizontal
6-pm sections with 200-pm intervals were
cut through the tissue block, from lower
urethra up to the upper half of the urinary
bladder. The sections were stained with
routine hematoxylin and eosin, dehydrated, and mounted with Permount. The
124
An extensive squamous metaplasia was
observed in the periurethral collecting
ducts, as well as in the periurethral parts of
coagulating glands, when castrated
neoDES animals fed a soy-free diet were
treated with estrogen pellets (50 pg of 17pestradiol per pellet) for 10 days or with
daily injections (25 pg of 17p-estradiol per
day) for 7 days (Figure 1A,B)
When adult neoDES animals were kept
on a soy-containing diet for 10 or 21 days
after castration, no signs of squamous
epithelial metaplasia could be observed.
Soy feeding did not prevent the metaplastic
reaction induced by 17 3-estradiol implants
(Figure 1C,D).
Coumestrol (50 pg per day for 7 days
given sc) did not induce squamous metaplasia in neoDES animals. Neither did it
inhibit the metaplastic reaction induced by
1 71B-estradiol injections (Figure 1 E,F).
Thus, based on squamous epithelial metaplasia, there is no evidence that either
coumestrol or dietary soy are estrogenic or
antiestrogenic.
Environmental Health Perspectives
PHYTOESTROGENACTION IN MOUSE PROSTATE
A
150
*i
125-
.s
100
75
Oil
Figure 1. Microscopic structure of prostatic collecting ducts in the posterior periurethral region of an adult castrated neoDES mouse kept on soyfree diet. (A) treated with an sc implant containing 50 pg estradiol and kept on
soyfree diet for 7 days; (B) given a soy-containing diet for 10 days postcastration; (C) treated with an sc implant
with 50 pg estradiol and kept on a soy-containing diet for 10 days postcastration; (D) treated with 50 pg coumestrol in DMSO sc per day for 7 days postcastration; (E) treated sc with 25 pg estradiol; and (F) 50 pg coumestrol in
DMSO for 7 days postcastration.
Discussion
glands were reduced but the differences
Despite the greater estrogen sensitivity, no were not statistically significant (7).
evidence for the estrogenicity of dietary soy
Coumestrol, one of the most potent
(diet with 7% of roasted soy meal) was phytoestrogens, was also incapable of
found in the prostate of neonatally estroge- inducing metaplastic transformation in
nized, adult castrated male mice when neonatally estrogenized mice; as docujudged on the basis of development of mented earlier, it did not inhibit the prosquamous epithelial metaplasia. The lack of
static growth when administered to normal
the estrogenicity of soy is in contrast to the adult rats (13). However, when the inducfindings in the immature female mouse in tion of the expression of estrogen-responwhich the estrogenicity of diet with 7% of sive gene, c-fos (one of the immediate early
roasted soy meal was confirmed by the uter- genes in mitosis) in adult neoDES mice
ine growth response (7). The estrogenlike was used as an end point, both coumestrol
effect by dietary soy was also demonstrable and daidzein showed weak estrogenlike
on the prostatic growth in the male rat
activity. Also in rat uterus the antiestrogen
when exposed to dietary soy from fertiliza- tamoxifen was shown to induce a weak
tion onward: the size of the ventral prostate response in c-fos expression (14). This
was reduced at 2 months of age (13). In the
weak estrogenlike (or antiestrogenlike)
corresponding feeding experiment with the effect is induced by phytoestrogen doses
male mouse, the sizes of the sex accessory comparable to the amounts ingested by
Volume 103, Supplement 7, October 1995
E2
Cou
Dai
inject-on
Figure 2. Effects of 171-estradiol, coumestrol,
daidzein, and soy diet on c-fos in the prostatic urethra
and coagulating gland of castrated neoDES male mice.
Abbreviations: Oil, vehicle only; E2, 17f-estradiol (100
pg sc); Cou, coumestrol (200 pg sc); Dai, daidzein (200
pg sc). (A) Effect of 17)3-estradiol, coumestrol, daidzein
on the expression of c-fos in the prostatic urethra of
castrated neoDES mice. The bars show the combined
data from all experiments. Values are expressed as percentages of expression after 3-hr E2-treatment (using
the corrected scanning units of c-fos relative to 28S).
Each bar represents the expression in three to nine animals. (B) A representative Northern blot from one
experiment. Lane 1-vehicle only (oil), 3 hr; lane 2-E2,
3 hr; lane 3-E2, 6 hr; lane 4-E2, 12 hr; lane 5-coumestrol, 3 hr; lane 6-coumestrol, 6 hr; lane 7-coumestrol,
12 hr; lane 8-daidzein, 3 hr; lane 9-daidzein, 6 hr; lane
10-daidzein, 12 hr. Each sample consists of mRNA from
three animals. (C) Effect of dietary soy on the estradiolinduced expression of c-fos in the coagulating gland of
castrated neoDES mice. Lane 1, soyfree diet from castration onward plus treatment with vehicle only; lane 2,
soyfree diet from castration onward plus treatment with
17p3-estradiol (100 pg sc); lane 3, soy diet from castration onward plus treatment with 17j3-estradiol (100 pg
sc). Injections were given on day 7 postcastration and all
samples were taken 3 hr after injection. Corresponding
ethidium bromide (E + Br) staining is shown below c-fos.
125
MAKELA ETAL.
laboratory rodents in daily soy-based feed (coumestrol, daidzein, genistein) are clearly
(15) and may therefore be of significance estrogen agonists in breast cancer cells in
for the effects associated with the high vitro and act through the estrogen receptor
(ER)-mediated mechanisms (21,22).
intake of dietary soy.
The weak estrogenicity of coumestrol Phytoestrogens with high binding affinities
seen in the adult male is again contradic- for estrogen receptor are also most active
tory with the findings in female rodents. It biologically (e.g., they enhance cell prolifis very well documented that coumestrol is eration) (23). Phytoestrogens are supposed
a potent estrogen in the developing female to act as antiestrogens by competing with
reproductive tract. It had DES-like effects more potent endogenous estrogens for the
in the neonatal female mouse (16) and binding to ER. Dietary estrogens reprepromoted uterine growth in immature rats senting three structurally different groups
when given in doses (per body weight) (coumestans, isoflavonoids, and resorcyclic
similar to those we used (15,17-19). In acid lactones) had additive effects with
adult ovariectomized rats, coumestrol 17p-estradiol in the presence of the conshowed partial estrogen agonism; it was centration giving submaximal stimulation,
uterotrophic but did not induce ovum and none of the phytoestrogens we studied
implantation in mated, ovariectomized (at concentrations below 1 PM) reduced
gestagen-maintained animals (20). The the proliferation rate of breast cancer cells,
conflicting findings on the hormonal i.e., had antiestrogenic effects in the prespotency of soy or coumestrol cannot yet be ence of 17p-estradiol (22).
In addition to the interaction with ER,
explained, but they could be due to sex- or
age-related differences in the uptake or dietary estrogens or structurally related
metabolism of phytoestrogens.
compounds might compete with endogeIt is also intriguing that in adult male nous estrogens for the active site of the
mice soy did not block the estrogen- estrogen-biosynthesizing and estrogeninduced metaplastic transformation or metabolizing enzymes and thus reduce the
expression of c-fos protooncogene, and concentration of biologically active
coumestrol did not inhibit the development endogenous estrogens. Coumestrol and
of metaplasia in 17p-estradiol-treated ani- genistein have been shown to inhibit the
mals. This is in conflict with the idea of the reduction of estrone to 170-estradiol by
antiestrogenicity of soy seen as reduction of estrogen-specific 17p-hydroxysteroid oxithe growth inhibition of the prostate and doreductase type 1 (EC 1.1.1.62, also
prevention of dysplastic development after known as 17,B-hydroxysteroid dehydrogeneonatal estrogenization and the reduction nase type 1, 17P-HSD type 1) (24). This
of the estrogen-induced growth of imma- enzyme is expressed in steroidogenic cells
ture uterus (7). One could interpret these such as ovarian granulosa cells and placenfindings by assuming that in males the tal trophoblasts, as well as in some target
neonatal or prepubertal period would be tissues of estrogen action, such as normal
more critical for estrogen and antiestrogen and malignant breast and endometrium.
actions. Once initiated, the estrogen-related The antibody against estrogen-specific 17phydroxysteroid oxidoreductase stains the
lesions would develop spontaneously.
It is not easily concievable how soy or urethral epithelium in the mouse (25) as
phytoestrogens could antagonize the estro- well as in man (26). The immunostaining
gen action at the target cells. Phytoestrogens of epithelium extends to the periurethral
parts of the dorsolateral lobes, coagulating
glands, and seminal vesicles in the mouse.
These are also the sites where metaplastic
epithelium and most dysplastic lesions are
found. Changes in the 17p-oxidoreduction
status of endogenous estrogens (estradiol
and estrone) may considerably modify the
biological activities of these hormones.
This would have biological significance if
continuous estrogen stimulation were
needed for the development of dysplasia.
At present, there is no direct evidence to
support this hypothesis.
Moreover, the possibility remains that
the chemopreventive action of soy is not
due to the antiestrogenicity of soy-derived
phytoestrogens. At very high concentrations, phytoestrogens are reported to have
effects not related to estrogen action.
Genistein, an isoflavonoid phytoestrogen,
is a potent inhibitor of both estrogen
receptor negative and positive breast cancer
cells (27) and of tyrosine protein kinase
activity of several growth factor receptors
and oncogenes that may be associated with
tumor cell growth (28). Further, the inhibition of DNA topoisomerase II has been
suggested as an alternative mechanism for
the action of isoflavones (29). Genistein is
also an inhibitor of angiogenesis, which
may partly explain the possible antitumor
activity of phytoestrogens (30). The relevance of these mechanisms for understanding the possible antiestrogenic action of soy
or soy-derived estrogens in the male mouse
is not known. It is noteworthy that soy had
no general inhibitory effect on prostatic
growth in neonatally untreated animals (7).
In addition to phytoestrogens, soybeans
contain several other potential anticarcinogenic agents such as protease inhibitors,
phytosterols, saponins, and inositol hexaphosphate (1,31); their possible roles as
chemopreventive agents cannot be excluded
in the present model.
REFERENCES
1. Barnes S, Grubbs C, Setchell KDR, Carlson J. Soybeans inhibit
mammary tumors in models of breast cancer. In: Mutagens and
Carcinogens in Diet (Pariza MW, Aeschbacher H-U, Felton JS,
Sato S, eds). New York:Wiley-Liss, 1990;239-253.
2. Hirono I, Funahashi M, Kaneko C, Ogino H, Ito M, Yoshida
A. Gastric lesions in rats fed salted food materials commonly
eaten by Japanese. Nutr Cancer 14:127-132 (1990).
3. Nagahara A, Benjamin H, Storkson J, Krewson J, Sheng K, Liu
W, Pariza MW. Inhibition of benzo[a]pyrene-induced mouse
forestomach neoplasia by a principal flavor component of
Japanese-style fermented soy sauce. Cancer Res 52:1754-1756
(1992).
4. Severson RK, Nomura AMY, Grove JS, Stemmermann GN. A
126
5.
6.
7.
8.
prospective study of demographics, diet, and prostate cancer
among men of Japanese ancestry in Hawaii. Cancer Res
49:1857-1860 (1989).
Pylkkanen L, Santti R, Newbold R, McLachlan JA. Regional
differences in the prostate of the neonatally estrogenized mouse.
Prostate 18:117-129 (1991).
Pylkkinen L, Mdkeld S, Valve E, Harkonen P, Santti R.
Prostatic dysplasia associated with increased expression of c-myc
in neonatally estrogenized mice. J Urol 149:1593-1601 (1993).
Mdkeld S, Pylkkinen L, Santti R, Adlercreutz H. Dietary
soybean may be antiestrogenic in male mouse. J Nutr
125:437-445 (1995).
Sakr WA, Haas GP, Cassin BF, Pontes JE, Crissman JD. The
Environmental Health Perspectives
PHYTOESTROGEN ACTION IN MOUSE PROSTATE
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
frequency of carcinoma and intraepithelial neoplasia of the
prostate in young male patients. J Urol 150:379-385 (1993).
Adlercreutz H, Honjo H, Higashi A, Fotsis T, Hamaildinen E,
Hasegawa T, Okada H. Urinary excretion of lignans and
isoflavonoid phytoestrogens in Japanese men and women consuming a traditional Japanese diet. Am J Clin Nutr
54:1093-1100 (1991).
Adlercreutz H, Markkanen H, Watanabe S. Plasma concentrations of phyto-oestrogens in Japanese men. Lancet
342:1209-1210 (1993).
Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate-plienol-chloroform extraction. Anal Biochem 162:156-159 (1987).
Loose-Mitchell DS, Chiapetta C, Stancel GM. Estrogen regulation of c-fos messenger ribonucleic acid. Mol Endocrinol
2:946-951 (1988).
MAkela S, Santti R, Martikainen P. Nienstedt W, Paranko J.
The influence of steroidal and nonsteroidal estrogens on the
5a-reduction of testosterone by the ventral prostate of the rat. J
Steroid Biochem 35:249-256 (1990).
Kirkland JL, Murthy L, Stancel GM. Tamoxifen stimulates
expression of the c-fos protooncogene in rodent uterus. Mol
Pharmacol 43:709-714 (1993).
Whitten PL, Naftolin F. Effects of a phytoestrogen diet on
estrogen-dependent reproductive processes in immature female
rats. Steroids 57:56-61 (1992).
Burroughs CD, Mills KT, Bern HA. Reproductive abnormalities in female mice exposed neonatally to various doses of
coumestrol. J Toxicol Environ Health 30:105-122 (1990).
Folman Y, Pope GS. The interaction in the immature mouse of
potent oestrogens with coumestrol, genistein and other uterovaginotrophic compounds of low potency. J Endocrinol
34:215-225 (1966).
Folman Y, Pope GS. Effect of norethisterone acetate, dimethylstilboestrol, genistein and coumestrol on uptake of [3H]oestradiol by uterus, vagina and skeletal muscle of immature mice. J
Endocrinol 44:213-218 (1969).
Whitten PL, Russell E, Naftolin F. Effects of a normal, humanconcentration, phytoestrogen diet on rat uterine growth.
Steroids 57:98-106 (1992).
Perel E, Lindner HR. Dissociation of uterotrophic action from
implantation-inducing activity in two non-steroidal oestrogens
(coumestrol and genistein). J Reprod Fertil 21:171-175 (1970).
Volume 103, Supplement 7, October 1995
View publication stats
21. Mayr U, Butsch A, Schnieder S. Validation of two in vitro test
systems for estrogenic activities with zearalenone, phytoestrogens and cereal extracts. Toxicology 74:135-149 (1992).
22. Mdkela S, Davis VL, Tally WC, Korkman J, Salo L, Vihko R,
Santti R, Korach K. Dietary estrogens act through estrogen
receptor mediated processes and show no antiestrogenicity in
cultured breast cancer cells. Environ Health Perspect
102:572-578 (1994).
23. Martin PM, Horwitz KB, Ryan DS, McGuire WL.
Phytoestrogen interaction with estrogen receptors in human
breast cancer cells. Endocrinology 103:1860-1867 (1978).
24. Mikela S, Poutanen M, Lehtimiki J, Kostian ML, Santti R,
Vihko R. Estrogen-specific 170-hydroxysteroid oxidoreductase
type 1 (E.C. 1.1.1.62) as a possible target for the action of phytoestrogens. Proc Soc Exp Biol Med 208:51-59 (1995).
25. Pylkkanen L, Santti R, Maentausta 0, Vihko R. Distribution
of estradiol-17P hydroxysteroid oxidoreductase in the urogenital tract of control and neonatally estrogenized male mice:
immunohistochemical, enzymehistochemical, and biochemical
study. Prostate 20:59-72 (1992).
26. Pylkkanen L, Santti R, Salo L, Maentausta 0, Vihko R, Nurmi
M. Immunohistochemical localization of estrogen-specific 170hydroxysteroid oxidoreductase in the human and mouse
prostate. Prostate 25:292-300 (1994).
27. Peterson G, Barnes S. Genistein inhibition of the growth of
human breast cancer cells - independence from estrogen receptors and multidrug resistance gene. Biochem Biophys Res
Comm 179:661-667 (1991).
28. Akiyama T, Ishida J, Nakagawa S, Ogawara S, Watanabe S,
Itoh N, Shibuya M, Fukami Y. Genistein, a specific inhibitor
of tyrosine-specific protein kinases. J Biol Chem
262:5592-5595 (1987).
29. Markovitz J, Linassier C, Fosse P, Couprie J, Jaquemin-Sablon
A, Pecq JB, Larson AK. Inhibitory effects of the tyrosine kinase
inhibitor genistein on mammalian DNA topoisomerase II.
Cancer Res 49:5111-5117 (1987).
30. Fotsis T, Pepper M, Adlercreutz H, Fleischmann G, Hase T,
Montesano R, Schweigerer L. Genistein, a dietary-derived
inhibitor of in vitro angiogenesis. Proc Natl Acad Sci USA
90:2690-2694 (1993).
31. Messina M, Barnes S. The role of soy products in reducing risk
of cancer. J Natl Cancer Inst 83:541-546 (1991).
127